Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Edge-GPU Breast Tomosynthesis Box Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The edge-gpu breast tomosynthesis box market has seen significant growth in recent years. Its value is set to increase from $0.53 billion in 2025 to $0.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.3%. This historical expansion can be attributed to several factors, including the increasing embrace of breast tomosynthesis technology, the progress in edge-gpu computing, a growing need for high-resolution 3D imaging, the proliferation of breast cancer screening programs, and breakthroughs in imaging detectors.
The edge-gpu breast tomosynthesis box market size is projected to experience substantial growth in the upcoming years. It is forecast to achieve a value of $0.99 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This expansion throughout the forecast period is driven by elements such as AI-driven diagnostic tools, the proliferation of portable screening units, integration with cloud imaging platforms, enhanced image processing speeds, and increased implementation in both research and clinical environments. Significant trends anticipated during this period encompass real-time 3D imaging, GPU-accelerated processing, improved diagnostic accuracy, AI-based image analysis, and portable imaging solutions.
Get A Free Sample Report With In-Depth Market Insights:
Edge-GPU Breast Tomosynthesis Box Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing incidence of breast cancer is anticipated to boost the expansion of the edge-GPU breast tomosynthesis box market in the future. Breast cancer is defined as a condition where abnormal cells within the breast proliferate without control, creating a malignant tumor that might metastasize to other bodily regions; however, early identification via screening and public awareness considerably enhances treatment results and survival chances. The growing occurrence of breast cancer is primarily attributable to shifts in lifestyle, given that elements like inadequate nutrition, decreased physical exercise, and hormonal impacts elevate the likelihood of aberrant cell proliferation in breast tissue, leading to a greater number of diagnoses worldwide over time. The edge-GPU breast tomosynthesis box assists in addressing breast cancer through its provision of high-resolution 3D imaging, facilitating the early and precise identification of tumors, enhancing diagnostic accuracy, and enabling quicker, more streamlined image processing for improved treatment strategies. For example, in July 2024, data from the American Cancer Society (ACS), a U.S.-based non-profit organization focused on cancer research, education, and patient assistance, indicated that in 2024, approximately 310,720 new invasive breast cancer cases are projected to be diagnosed among U.S. women, with 16% affecting individuals under 50, alongside an anticipated 56,500 additional cases of DCIS (stage 0). Consequently, the increasing incidence of breast cancer is fueling the expansion of the edge-GPU breast tomosynthesis box market.
Edge-GPU Breast Tomosynthesis Box Market Segment Breakdown: Which Categories Lead On Revenue?
The edge-gpu breast tomosynthesis box market covered in this report is segmented –
1) By Product Type: Standalone Edge-GPU Box, Integrated Edge-GPU Systems
2) By Distribution Channel: Direct Sales, Distributors, Other Distribution Types
3) By Application Type: Breast Cancer Screening, Diagnostic Imaging
4) By End-User: Hospitals, Diagnostic Centers
Subsegments:
1) By Standalone Edge-GPU Box: Compact Edge-GPU Box, High-Performance Edge-GPU Box, Modular Edge-GPU Box
2) By Integrated Edge-GPU Systems: Hospital Integrated Systems, Diagnostic Center Integrated Systems
#Edge-GPU Breast Tomosynthesis Box Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the Edge-GPU breast tomosynthesis segment are prioritizing technological advancements, particularly in accelerated image processing, to boost image sharpness, decrease scan durations, and refine the precision of early breast cancer detection. This accelerated image processing involves leveraging high-performance computing solutions, including GPUs or dedicated hardware, to quickly process and refine digital images. This facilitates quicker reconstruction, analysis, and visualization of intricate imaging data, thereby enhancing efficiency and accuracy within medical imaging practices. An example is the launch in June 2025 by QT Imaging, Inc., a U.S.-based medical device firm, of its advanced breast imaging reconstruction software. This software, utilizing NVIDIA L40 GPU acceleration, offers expedited and more accurate image processing, heightened diagnostic precision, and better workflow efficiency for medical professionals, representing a notable leap forward in breast imaging technology. The objective of this introduction is to optimize breast cancer screening through faster and more accurate detection capabilities, easing the workload for radiologists, and ultimately contributing to better patient outcomes via sophisticated, high-speed imaging technology.
Edge-GPU Breast Tomosynthesis Box Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the edge-gpu breast tomosynthesis box market are Hologic Inc., GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers, Canon Medical Systems Corporation, Planmed Oy, Metaltronica S.p.A., General Medical Merate (IMS GIOTTO), Villa Sistemi Medicali, DMS Imaging, DRTECH Corporation, Stephanix, Delphinus Medical Technologies, Konica Minolta, Carestream Health, Agfa-Gevaert N.V., IDETEC Medical Imaging, Xenox (Xenox Medical), Aurora Imaging Technology, Micrima Ltd., Neusoft Medical Systems, Landwind Medical
View The Full Edge-GPU Breast Tomosynthesis Box Market Report:
Edge-GPU Breast Tomosynthesis Box Market Geographic Spread And Regional Opportunities
North America was the largest region in the edge-GPU breast tomosynthesis box market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the edge-gpu breast tomosynthesis box market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
